Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Cancer Prevention: Lowering your Risk

Assay for Monitoring and Treating Malignant Brain Tumors

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Using Biomarkers to Detect Cancer

Extracellular Vesicles as Floating Cancer Biomarkers

Is Cancer a Metabolic Disorder?

TARDIS: The Improved Method of Detecting Breast Cancer

Overview of Cell Viability and Cytotoxicity

Metastatic Migration in Cancer may be Influenced by Metabolism

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

What is Cancer of Unknown Primary?

See more featured articles »

Hot vs Cold: the differences between tumor types

Cancer Symptoms

Cutaneous Manifestations of Internal Malignancy

CDK9 and Cancer

Cancer Pain

Effects of Social and Economic Deprivation on Cancer Mortality

Hypoxia Markers and Their Importance

Caring for a Loved One with Cancer

Cancer Diagnosis

Secondary Lung Cancer

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Insights into Oncofertility

What is the Tumor Microenvironment?

Pediatric Cancer

Targeted Cancer Therapies

Microfluidic cancer treatment screen combined with flow cytometry

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Cancer History

Cancer Pain Management

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Cancer Pathophysiology

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Cancer Glossary

Acidosis and Tumor Progression

Secondary Brain Cancer

British Pioneers in Cancer Biology

Transforming Cancer Care through Genomic Testing

Insight into Cancer Vaccines

What Role do Biobanks Play in Cancer Research?

Cancer Epidemiology

Cancer Research

What is Cancer?

What is Immunochemotherapy?

Why are Cancer Cell Lines Useful?

What is Tumorigenesis?

Cancer Prognosis

Myc Mutations and Cancer

Living with Cancer Pain

Cancer Screening Considerations: Balancing the Benefits and Risks

The Effects of Cancer on Family Life

What is Merkel Cell Carcinoma?

Cancer Management

Investigating the Molecular Mechanisms of Cancer

Exploiting Enzymes in Cancer Diagnosis and Therapy

The Biochemistry of Breast Cancer Screening

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Cancer Classification

What Causes Cancer?

The Cancer Cell Surface Proteome as a Therapeutic Target

Latest Cancer News and Research

International urology conference showcases advancements in prostate cancer diagnostics

Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26), taking place in London from 13–16 March 2026.

12 Mar 2026

Scientists uncover how the immune system actively builds food tolerance

Food allergies are serious and, for some, potentially deadly. And yet, despite decades of research into allergies and what causes them, very little is known about why the vast majority of people are able to tolerate foods that can sicken or even kill others.

11 Mar 2026

Apixaban safer than rivaroxaban for treating venous thrombosis

The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban is safer than rivaroxaban, with fewer bleeding complications.

11 Mar 2026

Review explores how generative AI could support precision oncology decision-making

A narrative review examines how generative AI tools such as large language models and vision-language models could assist precision oncology by interpreting genomic data, matching patients to clinical trials, and synthesizing complex clinical information. The authors emphasize governance, human oversight, and retrieval-based safeguards to ensure these systems are deployed safely in cancer care.

11 Mar 2026

Simplified nanoparticles "educate" the immune system to find and destroy disease-causing cells

Johns Hopkins Medicine scientists say they have developed a simplified version of biodegradable nanoparticles that can "educate" the immune system to find and destroy disease-causing cells throughout the body.

11 Mar 2026

Dual-positive hybrid cells linked to shorter survival in advanced breast cancer

An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian.

11 Mar 2026

Severe COVID and flu infections increase risk of lung cancer

Severe COVID-19 and influenza infections prime the lungs for cancer and can accelerate the disease's development, but vaccination heads off those harmful effects, new research from UVA Health's Beirne B. Carter Center for Immunology Research and UVA Comprehensive Cancer Center indicates.

11 Mar 2026

Disrupting protein production in tumors triggers potent immune responses

A new study led by Pierre Close's team (GIGA, Laboratory of Cancer Signaling, and WELRI Investigator) reveals how subtly disrupting the way tumors produce their proteins can trigger a potent antitumor immune response.

11 Mar 2026

Scientists map epigenetic changes across aging brain cells

Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to Parkinson's to ALS and beyond, is expected to double every 20 years.

11 Mar 2026

Geographic location strongly influences stage of breast cancer diagnosis

Where a woman lives significantly affects whether her breast cancer is diagnosed at an early or late stage, according to a national analysis published in the Journal of the American College of Surgeons (JACS).

11 Mar 2026

Study links migration transition to changing cancer incidence patterns

North Korean defectors who resettled in South Korea share genetics but markedly contrasting early-life exposures with South Korean residents.

11 Mar 2026

DNA origami vaccine platform shows promise against multiple infectious viruses

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December 2020 and mathematical models suggest that mRNA vaccines prevented at least 14.4 million deaths from COVID-19 in the first year alone.

11 Mar 2026

Rapid Novor receives Ontario Ministry of Health provisional license for EasyM® blood-based MRD test for multiple myeloma

Rapid Novor Inc., a Canadian biotechnology leader, announced today that its diagnostic laboratory has received a provisional license from the Ontario Ministry of Health (MOH) for its EasyM® assay, enabling the company to begin testing patients in Canada.

From Rapid Novor Inc 11 Mar 2026

Alginate-enhanced gel improves organoid development

Miniature organs grown in the lab can organize themselves into complex shapes. But they never do it the same way twice, which makes it hard to use these so-called 'organoids' to study disease.

10 Mar 2026

New consensus defines oligometastatic stage in pancreatic cancer

Until now, the following has been true for metastatic pancreatic cancer: Once the tumor has spread, local treatment such as surgery is usually no longer an option.

10 Mar 2026

Boron-assisted reactions overcome solubility barriers in protein synthesis

Chemists from ETH Zurich have found a way to produce poorly soluble proteins by caging a uniquely reactive boron compound.

10 Mar 2026

Low baseline testosterone predicts aggressive prostate cancer progression risk

A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a more aggressive form while under active surveillance.

10 Mar 2026

Hormone asprosin linked to long-term weight changes after menopause

Researchers at the University of California, Irvine Joe C. Wen School of Population & Public Health have identified how the hormone asprosin influences long-term weight change among postmenopausal women in the United States.

10 Mar 2026

Depleting a clotting protein fibrinogen could slow down pancreatic cancer

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have found that depleting a clotting protein made by the liver could slow down pancreatic cancer.

10 Mar 2026

Air pollution may be lowering global IQ and widening inequality, researchers warn

Researchers argue that exposure to fine particulate air pollution (PM2.5) may affect cognitive function and intelligence, potentially causing large population-level losses in global IQ. Using modelling based on published exposure–response data, the authors estimate that pollution could be associated with tens of billions of IQ points lost worldwide, with the largest impacts in lower-income regions.

10 Mar 2026